Global Single Cell RNA Sequencing Solution Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Single Cell RNA Sequencing Solution Market Insights, Forecast to 2034
Single-cell RNA sequencing (scRNA-seq) is a cutting-edge technology that allows researchers to analyze the gene expression profiles of individual cells within a tissue or sample. The scRNA-seq solution comprises a combination of laboratory protocols, sequencing platforms, and computational tools specifically designed for the analysis of single-cell transcriptomes.
Market Analysis and InsightsGlobal Single Cell RNA Sequencing Solution Market
Global Single Cell RNA Sequencing Solution market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Single Cell RNA Sequencing Solution industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global market for single-cell RNA sequencing solutions has been experiencing significant growth in recent years. The adoption of scRNA-seq technology has revolutionized the field of genomics and biomedical research, allowing researchers to gain unprecedented insights into cellular heterogeneity and gene expression at the single-cell level. The continuous advancements in genomic research and the growing need for in-depth analysis of individual cells have driven the demand for scRNA-seq solutions. scRNA-seq has found applications in various fields, including cancer research, immunology, neuroscience, stem cell research, and precision medicine, further contributing to its market growth. The global market for single-cell RNA sequencing solutions is expected to continue its rapid growth in the coming years. Advancements in technology, improvements in data analysis tools, and the declining costs of sequencing are likely to drive wider adoption across research institutions and industries. Additionally, the application of scRNA-seq in clinical settings and its potential integration with other omics technologies may further expand its market reach.
Report Covers
This report presents an overview of global Single Cell RNA Sequencing Solution market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Single Cell RNA Sequencing Solution market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
TAKARA BIO
BioCat GmbH
Thermo Fisher Scientific
Roche Holding AG
PerkinElmer
Dolomite Bio
Illumina
Witec AG
10x Genomics, Inc
Oxford Nanopore Technologies
QIAGEN
LC Sciences
Pacific Biosciences
Scipio bioscience
CD Genomics
Segment by Type
Equipment
Service
Software
Research Institutions
Bioscience Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Single Cell RNA Sequencing Solution introduction, etc. Single Cell RNA Sequencing Solution Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Single Cell RNA Sequencing Solution
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Single Cell RNA Sequencing Solution Market
Global Single Cell RNA Sequencing Solution market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Single Cell RNA Sequencing Solution industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global market for single-cell RNA sequencing solutions has been experiencing significant growth in recent years. The adoption of scRNA-seq technology has revolutionized the field of genomics and biomedical research, allowing researchers to gain unprecedented insights into cellular heterogeneity and gene expression at the single-cell level. The continuous advancements in genomic research and the growing need for in-depth analysis of individual cells have driven the demand for scRNA-seq solutions. scRNA-seq has found applications in various fields, including cancer research, immunology, neuroscience, stem cell research, and precision medicine, further contributing to its market growth. The global market for single-cell RNA sequencing solutions is expected to continue its rapid growth in the coming years. Advancements in technology, improvements in data analysis tools, and the declining costs of sequencing are likely to drive wider adoption across research institutions and industries. Additionally, the application of scRNA-seq in clinical settings and its potential integration with other omics technologies may further expand its market reach.
Report Covers
This report presents an overview of global Single Cell RNA Sequencing Solution market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Single Cell RNA Sequencing Solution market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
TAKARA BIO
BioCat GmbH
Thermo Fisher Scientific
Roche Holding AG
PerkinElmer
Dolomite Bio
Illumina
Witec AG
10x Genomics, Inc
Oxford Nanopore Technologies
QIAGEN
LC Sciences
Pacific Biosciences
Scipio bioscience
CD Genomics
Segment by Type
Equipment
Service
Software
Segment by Application
Research Institutions
Bioscience Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Single Cell RNA Sequencing Solution introduction, etc. Single Cell RNA Sequencing Solution Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Single Cell RNA Sequencing Solution
Chapter 13Methodology and Data Sources adopted by MRAResearch